Abstract
A metabolic basis for barbiturate amelioration of ischemic brain damage is not demonstrable in terms of the rate and magnitude of changes in brain high energy phosphates, glycolytic metabolites and Krebs cycle intermediates during (7,8) or after (9) complete global brain ischemia. Yet, the efficacy of barbiturate therapy in improving neurologic recovery when administered before (4) or after (2) complete global ischemia has been clearly demonstrated.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.